During the past decade, TRIO - Comprehensive Cancer Centers of Nevada conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "TRIO - Comprehensive Cancer Centers of Nevada" #1 collaborator was "Janssen Biotech, Inc., including Johnson & Johnson" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "TRIO - Comprehensive Cancer Centers of Nevada" are "Graft Vs Host Disease" (1 trials), "Leukemia, B-cell" (1 trials), "Lymphoma, B-Cell" (1 trials), "Lymphoma, Non-Hodgkin" (1 trials) and "Solid Tumor" (1 trials). Many other conditions were trialed in "TRIO - Comprehensive Cancer Centers of Nevada" in a lesser frequency.

Most popular intervention types in "TRIO - Comprehensive Cancer Centers of Nevada" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Ibrutinib" (1 trials) and "pemigatinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "TRIO - Comprehensive Cancer Centers of Nevada" are 2 trials for "All" genders.

Currently, there are NaN active trials in "TRIO - Comprehensive Cancer Centers of Nevada". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 1 completed trials in TRIO - Comprehensive Cancer Centers of Nevada, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in TRIO - Comprehensive Cancer Centers of Nevada, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".